Adaptive Biotechnologies Corp (NAS:ADPT)
$ 4.7 0.04 (0.86%) Market Cap: 693.12 Mil Enterprise Value: 490.99 Mil PE Ratio: 0 PB Ratio: 2.87 GF Score: 76/100

Q3 2020 Adaptive Biotechnologies Corp Earnings Call Transcript

Nov 10, 2020 / 09:30PM GMT
Release Date Price: $47.07 (-2.10%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to Adaptive Biotechnologies Third Quarter 2020 Conference Call. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Ms. Karina Calzadilla. Thank you. Please go ahead, ma'am.

Karina Calzadilla

Thank you, Boena, and good afternoon, everyone. I would like to welcome you to Adaptive Biotechnologies Third Quarter 2020 Earnings Conference Call. Earlier today, we issued a press release reporting Adaptive's financial results for the third quarter of 2020. The press release is available at adaptivebiotechnologies.com.

We are conducting a live webcast of this call and will be referencing to a slide presentation that has been posted to the Investors section in our corporate website. During the call, management will make projections and other forward-looking statements within the meaning of federal securities laws regarding future events and the future financial performance of the company. These statements reflect management's current perspective of the business

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot